About tenon medical inc - TNON
Tenon Medical, Inc. is a medical device company, which engages in the development of a minimally invasive approach to the sacroiliac joint (SI joint) using a single titanium implant for treatment of the most common types of SI Joint disorders. The company was founded by Richard Ferrari and Richard Ginn on June 19, 2012 and is headquartered in Los Gatos, CA.
TNON At a Glance
TENON Medical, Inc.
104 Cooper Court
Los Gatos, California 95032
| Phone | 1-408-649-5760 | Revenue | 3.94M | |
| Industry | Medical/Nursing Services | Net Income | -12,556,000.00 | |
| Sector | Health Services | 2025 Sales Growth | 20.354% | |
| Fiscal Year-end | 12 / 2026 | Employees | 26 | |
| View SEC Filings |
TNON Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 1.781 |
| Price to Book Ratio | 5.252 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -0.565 |
| Enterprise Value to Sales | 1.644 |
| Total Debt to Enterprise Value | 0.022 |
TNON Efficiency
| Revenue/Employee | 151,692.308 |
| Income Per Employee | -482,923.077 |
| Receivables Turnover | 2.323 |
| Total Asset Turnover | 0.383 |
TNON Liquidity
| Current Ratio | 2.106 |
| Quick Ratio | 1.778 |
| Cash Ratio | 1.169 |
TNON Profitability
| Gross Margin | 59.787 |
| Operating Margin | -304.589 |
| Pretax Margin | -318.357 |
| Net Margin | -318.357 |
| Return on Assets | -121.885 |
| Return on Equity | -228.063 |
| Return on Total Capital | -242.347 |
| Return on Invested Capital | -225.179 |
TNON Capital Structure
| Total Debt to Total Equity | 2.798 |
| Total Debt to Total Capital | 2.721 |
| Total Debt to Total Assets | 1.31 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | N/A |